| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 78031 |
DOTA-c(RGDfK)DOTA偶联环肽 |
98 |
h |
2024-12-19 |
| 78032 |
SCN-DOTA-PCA DOTA-苯甲酰胺衍生物 |
126 |
h |
2024-12-19 |
| 78033 |
DOTA-N-羟基琥珀酰亚胺 DOTA-N-hydroxysuccinimide |
109 |
h |
2024-12-19 |
| 78034 |
低分子量CLT1肽靶向Gd(III)螯合物CLT1-dL-(Gd-DOTA) |
183 |
h |
2024-12-19 |
| 78035 |
DOTA-1,2-二硬脂酰-sn-甘油-3-磷酸乙醇胺脂质 |
170 |
h |
2024-12-19 |
| 78036 |
1,4,7-三氮杂环壬烷-1,4,7-三乙酸(NOTA17,19) |
120 |
h |
2024-12-19 |
| 78037 |
cas:1061569-06-9，4-formyl-N-(2-(2-hydroxyethoxy)ethyl)benzamide ADC抗体偶联药物 |
93 |
zyl |
2024-12-19 |
| 78038 |
DBCO-PEG4-VA-PBD，2241644-09-5，ADC定制 |
89 |
wyh |
2024-12-19 |
| 78039 |
Val-Cit-PAB-MMAE，cas:644981-35-1，ADC定制 |
106 |
wyh |
2024-12-19 |
| 78040 |
DOTA-GMSH 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)偶联α-黑素细胞刺激素(α-MSH)类似物 |
120 |
h |
2024-12-19 |
| 78041 |
mDPR-Val-Cit-PAB-MMAE，1491152-26-1，ADC定制 |
101 |
wyh |
2024-12-19 |
| 78042 |
G3-(Gd-DTPA)(24)DOTA-钆(Gd)大分子造影剂 |
217 |
h |
2024-12-19 |
| 78043 |
DOTA-多柔比星 DOTA-DOX |
128 |
h |
2024-12-19 |
| 78044 |
聚(HPMA)-c(RGDyK)-DOTA |
85 |
h |
2024-12-19 |
| 78045 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)螯合剂共轭的应变环辛烯衍生物二苄基环辛烯(DBCO) |
108 |
h |
2024-12-19 |
| 78046 |
PDDEC-NB；2-methyl-2-(pyridin-2-yldisulfanyl)propyl 4-nitrophenyl carbonate |
91 |
zyl |
2024-12-19 |
| 78047 |
(67)Ga-DOTA复合物共轭二膦酸盐(67)Ga-DOTA-Bn-SCN-HBP |
133 |
h |
2024-12-19 |
| 78048 |
MWCNT/PEI-FI-DOTA(Gd)-PEG 异硫氰酸荧光素(FI)和钆(Gd)螯合剂共价接枝聚乙烯亚胺修饰的多壁碳纳米管 |
134 |
h |
2024-12-19 |
| 78049 |
DOTA-Cys-hAb47 螯合剂DOTA偶联半胱氨酸-抗EphB4抗体hAb47和hAb131 |
177 |
h |
2024-12-19 |
| 78050 |
1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)-F(ab)2-曲妥珠单抗 |
106 |
h |
2024-12-19 |
| 78051 |
DOTA-MG11(DOTA-DGlu-Ala-Tyr-Gly-Trp-Met-Asp)DOTA肽缀合物 |
130 |
h |
2024-12-19 |
| 78052 |
AcLys-PABC-VC-Aur0101， cas:1438851-17-2，ADC定制 |
154 |
wyh |
2024-12-19 |
| 78053 |
cas:107348-47-0，2,5-dioxopyrrolidin-1-yl 3-(pyridin-2-yldisulfanyl)butanoate ADC抗体偶联药物 |
87 |
zyl |
2024-12-19 |
| 78054 |
SMCC-DM4 ， cas:1228105-52-9，ADC定制 |
90 |
wyh |
2024-12-19 |
| 78055 |
cas:1639939-40-4 Mal-Val-Ala-PAB-PNP |
98 |
zyl |
2024-12-19 |
| 78056 |
MA-PEG8-VA-PAB-SG3199，ADC定制 |
139 |
wyh |
2024-12-19 |
| 78057 |
Acid-PEG4-Val-Cit-PAB-MMAE |
86 |
zyl |
2024-12-19 |
| 78058 |
MC-Val-Cit-PAB-Indibulin，cas:2055896-95-0，ADC定制 |
95 |
wyh |
2024-12-19 |
| 78059 |
cas:1096584-62-1 Mal-Val-Cit-PAB-PNP |
100 |
zyl |
2024-12-19 |
| 78060 |
cas:863971-53-3 Fmoc-Val-Cit-PAB-PNP |
100 |
zyl |
2024-12-19 |
| 78061 |
MC-Sq-Cit-PAB-Dolastatin10 ，cas:1941168-65-5，ADC定制 |
110 |
wyh |
2024-12-19 |
| 78062 |
Mal-PEG2-Val-Cit-PAB-OH ADC抗体偶联药物 |
106 |
zyl |
2024-12-19 |
| 78063 |
N3-PEG4-DYKDDDD-Doxorubicin，ADC定制 |
116 |
wyh |
2024-12-19 |
| 78064 |
MA-vc-PAB-DM1 cas:1464051-44-2 |
80 |
zyl |
2024-12-19 |
| 78065 |
DBCO-PEG4-VC-PAB-DMAE-Duocarmycin SA |
112 |
zyl |
2024-12-19 |
| 78066 |
VC-PAB-DMAE-PNU159682 ADC抗体偶联药物 |
106 |
zyl |
2024-12-19 |
| 78067 |
MC-GGFG-DX8951 cas:1600418-29-8 |
88 |
zyl |
2024-12-19 |
| 78068 |
DOTA-NGR NGR肽偶联1,4,7,10-四氮杂环十二烷-N,N’,N”,N”’-四乙酸(DOTA) |
113 |
h |
2024-12-19 |
| 78069 |
N3-PEG4-vc-PAB-Doxorubicin 叠氮PEG修饰维生素C-阿霉素的介绍 |
217 |
zyl |
2024-12-19 |
| 78070 |
DOTA-Ahx-(d-Lys6-GnRH1)DOTA偶联的d-Lys6-GnRH肽 |
118 |
h |
2024-12-19 |
| 78071 |
DOTA-porphyrin 双功能螯合剂DOTA偶联5-(对-氨基-丙烯-氧苯基)-10,15,20-三-(对-羧基-甲基-烯-氧苯基)卟啉 |
138 |
h |
2024-12-19 |
| 78072 |
VC-SECO DUBA analogue，ADC定制 |
111 |
wyh |
2024-12-19 |
| 78073 |
DOTA-H-Lys(Boc)-OH-SWCNTs 赖氨酸胺手柄功能化的单壁碳纳米管偶联DOTA螯合剂 |
105 |
h |
2024-12-19 |
| 78074 |
[DOTA-A1]-ZHER2:S1 抗HER2 ZHER2:S1亲和体分子缀合DOTA |
168 |
h |
2024-12-19 |
| 78075 |
Vc-MMAD cas:1401963-17-4的结构式 |
86 |
zyl |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询